November 14, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Goldman Sachs Group, Inc. (“Goldman Sachs” or the “Company”) (NYSE: GS) concerning potential securities law violations. Investors who purchased Goldman Sachs securities may be affected.
November 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of MoneyGram International, Inc. (“MoneyGram” or the “Company”) (NASDAQ: MGI) concerning potential securities law violations. Investors who purchased MoneyGram securities may be affected.
November 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors of Yelp Inc. (“Yelp” or the “Company”) (NYSE: YELP).
November 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Stitch Fix, Inc. (“Stitch Fix” or the “Company”) (NASDAQ: SFIX). Investors who purchased Stitch Fix common stock between June 8, 2018 and October 1, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Northern District of California against Stitch Fix and certain executives on behalf of investors of Stitch Fix common stock during the Class Period.
November 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of NiSource Inc. (“NiSource” or the “Company”) (NYSE: NI) concerning potential securities law violations. Investors who purchased NiSource securities may be affected.
November 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bank OZK (“Bank OZK” or the “Company”) (NASDAQ: OZK). Investors who purchased Bank OZK securities between February 19, 2016 and October 18, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Eastern District of Arkansas against Bank OZK and certain former or current executives on behalf of investors that purchased or otherwise acquired Bank OZK securities during the Class Period.
November 2, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Trevena Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN). Investors who purchased Trevena securities between May 2, 2016 and October 9, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Eastern District of Pennsylvania against Trevena and certain executives on behalf of investors that purchased or otherwise acquired Trevena securities during the Class Period.
September 26, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Santa Clara, California-based Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG).
September 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Microchip Technology Inc. (“Microchip” or the “Company”) (NASDAQ: MCHP). Investors who purchased Microchip common stock between March 2, 2018 and August 9, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Arizona against Microchip and certain executives on behalf of investors that acquired Microchip common stock during the Class Period.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Pretium Resources, Inc. (“Pretium” or the “Company”) (NYSE: PVG). Investors who purchased Pretium securities between July 21, 2016 and September 6, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against Pretium and certain executives on behalf of investors that acquired Pretium securities during the Class Period.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Qurate Retail, Inc. (“Qurate” or the “Company”) (NASDAQ: QRTEA). Investors who purchased Qurate securities between August 5, 2015 and September 7, 2016 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Colorado against Qurate and certain executives on behalf of investors that acquired Qurate securities during the Class Period.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of AbbVie Inc. (“AbbVie” or the “Company”).
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of OPKO Health, Inc. (“OPKO” or the “Company”) (Nasdaq: OPK).
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of USA Technologies, Inc. (“USA Technologies” or the “Company”), which is based in Malverne, Pennsylvania (Nasdaq: USAT).
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Danske Bank A/S American Depository Shares (“Danske” or the “Company”) (OTC: DNKEY) (CUSIP: 236363206).
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CV Sciences, Inc. (“CV Sciences” or the “Company”) (OTC: CVSI). Investors who purchased CV Sciences common stock between June 19, 2017 and August 20, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Nevada against CV Sciences and certain executives on behalf of investors that acquired CV Sciences common stock during the Class Period.
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CBS Corporation (“CBS” or the “Company”) (NYSE: CBS). Investors who purchased CBS securities between February 14, 2014 and July 27, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against CBS and certain executives on behalf of investors that acquired CBS securities during the Class Period.
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Nevro Corporation (“Nevro” or the “Company”) (NYSE: NVRO). Investors who purchased Nevro common stock between January 8, 2018 and July 12, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Northern District of California against Nevro and certain executives on behalf of investors that acquired Nevro common stock during the Class Period.
August 22, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Impinj, Inc. (“Impinj” or the “Company”) (NASDAQ: PI). Investors who purchased Impinj securities between May 7, 2018 and August 2, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Central District of California against Impinj and certain executives on behalf of investors that acquired Impinj securities during the Class Period.
August 10, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sinclair Broadcast Group, Inc. (“Sinclair” or the “Company”) (NASDAQ: SBGI). Investors who purchased Sinclair securities between February 22, 2017 and July 19, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Maryland against Sinclair and certain executives of the Company on behalf of investors that purchased or otherwise acquired Sinclair common stock during the Class Period.
August 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Tesla, Inc. (“Tesla” or the “Company”) (NASDAQ: TSLA) concerning potential securities law violations. Investors who purchased Tesla securities may be affected.
August 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (NYSE: AMPE) concerning potential securities law violations. Investors who purchased Ampio securities may be affected.
August 1, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating GDS Holdings Limited (“GDS” or the “Company”) (NASDAQ: GDS) concerning potential securities law violations. Investors who purchased GDS American Depositary Shares, or “ADSs” that trade under the symbol GDS may be affected.
August 1, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. (“ACADIA” or the “Company”) (Nasdaq: ACAD). Investors who purchased ACADIA securities between April 29, 2016 and July 9, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court, Southern District of California against ACADIA and certain executives on behalf of investors that acquired ACADIA securities during the Class Period.
July 24, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Farmland Partners Inc. (“Farmland” or the “Company”) (NYSE: FPI). Investors who purchased Farmland securities between May 9, 2017 and July 10, 2018 (the “Class Period”) may be affected.
July 24, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Prothena Corporation plc (“Prothena” or the “Company”) (NASDAQ: PRTA). Investors who purchased Prothena common stock between October 15, 2015 and April 20, 2018 (the “Class Period”) may be affected. A Class Action has been filed against Prothena and certain current and former Company executives on behalf of investors who purchased Prothena’s publicly traded common stock during the Class Period.
July 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Glencore plc (“Glencore” or the “Company”) (OTC: GLNCY, GLCNF) concerning potential securities law violations. Investors who purchased Glencore securities may be affected.
July 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of Gogo Inc. (“Gogo” or the “Company”) (NASDAQ: GOGO). Investors who purchased or otherwise acquired Gogo securities between February 27, 2017 and May 7, 2018 (the “Class Period”) may be affected.
| Company | Ticker | Class Period | Deadline | Administrator | |
|---|---|---|---|---|---|
| Xencor, Inc. | XNCR | On behalf of all former holders of Xencor, Inc.'s (the "Company") Series A-E preferred stock whose shares were converted to A-1 stock in the Recapitalization. | 5/13/17 | Strategic Claims Services | |
| Molycorp, Inc. | MCP | 2/21/2012 - 10/15/2013 | 5/18/17 | Angeion Group | |
| Health Enhancement Products, Inc. (N/K/A Zivo Bioscience, Inc.) | HEPI | 10/31/2003 - 5/31/2004 | 5/18/17 | Rust Consulting, Inc. | |
| Barclays Bank PLC (Electronic Foreign Exchange Trading - BARX) | n/a | 6/1/2008 - 4/21/2016 | 5/19/17 | Garden City Group | |
| EZCORP, Inc. | EZPW | 4/19/2012 - 10/6/2014 | 5/19/17 | Garden City Group | |
| King Digital Entertainment plc | KING | 3/26/2014 - 9/22/2014 | 5/23/17 | Gilardi & Co. |
| Elan Corporation, plc | ELN | On behalf of all persons: (i) who sold Elan Corporation, plc American Depositary Receipts contemporaneously defendants' purchases of Elan ADRs during the period August 23, 2006 through and including June 17, 2008 at 2:00 am EDT; and/or (ii) who purchased Elan ADRs, purchased call options thereon, or sold put options thereon, contemporaneously with the defendants' sales of Elan ADRs, sale of call options thereon, or purchases of put options thereon, during the period July 21, 2008 through and including July 29, 2008 at 4:00 pm EDT | 5/29/17 | A.B. Data, Ltd. | |
| PTC Inc. | PTC | 11/24/2011 - 7/29/2015 | 5/30/17 | Strategic Claims Services | |
| Revance Therapeutics, Inc. | RVNC | 6/19/2014 - 5/1/2015 | 6/5/17 | Gilardi & Co. | |
| Molycorp, Inc. | MCP | 2/7/2011 - 11/10/2011 | 6/14/17 | Gilardi & Co. | |
| CBD Energy Limited (n/k/a BlueNRGY Group Limited) | CBDE; CBDF | 6/13/2014 - 10/24/2014 | 6/29/17 | Strategic Claims Services | |
| Allco Finance Group Limited (Australia) | AFG | 8/21/2007 - 2/27/2008 | 6/30/17 | Maurice Blackburn | |
| Ampio Pharmaceuticals, Inc. | AMPE | 1/13/2014 - 8/21/2014 | 7/5/17 | Garden City Group | |
| FireEye, Inc. | FEYE | On behalf of all those who purchased FireEye, Inc. common stock in its March 6th, 2014 Secondary Public Offering | 7/8/17 | Kurtzman Carson Consultants | |
| Federal Home Loan Mortgage Corporation (SEC) | FRE; FMCC | 4/18/2000 - 6/8/2003 | 7/10/17 | Gilardi & Co. | |
| Altisource Portfolio Solutions S.A. | ASPS | 4/25/2013 - 12/21/2014 | 7/11/17 | Garden City Group | |
| Geron Corporation | GERN | 12/13/2012 - 3/11/2014 | 7/11/17 | Epiq Systems, Inc. | |
| Ruby Tuesday, Inc. | RT | 4/10/2013 - 10/9/2013 | 7/17/17 | Gilardi & Co. | |
| Third Avenue Focused Credit Fund | TFCVX; TFCIX | 3/1/2013 - 12/10/2015 | 7/19/17 | Gilardi & Co. | |
| L-3 Communications Holdings, Inc. (N/K/A L3 Technologies, Inc.) | LLL | 1/30/2014 - 7/30/2014 | 7/29/17 | Garden City Group | |
| Energy Recovery, Inc. | ERII | 3/7/2013 - 3/5/2015 | 8/4/17 | Garden City Group | |
| Dole Food Company, Inc. | DOLE | On behalf of all persons or entities who sold Dole Food Company, Inc.'s ("Dole" or the "Company") common stock (i) during the period from January 2, 2013 through October 31, 2013, inclusive, or (ii) on November 1, 2013 where those shares were sold on the open market and were not held as of the closing of the Take-Private Transaction. | 8/9/17 | JNG Legal Administration | |
| Halliburton Company | HAL | 8/16/1999 - 12/7/2001 | 8/12/17 | JND Legal Administration | |
| KBR, Inc. | KBR | 9/11/2013 - 7/30/2014 | 8/19/17 | Epiq Systems, Inc. | |
| DFC Global Corp. | DLLR | 1/28/2011 - 2/3/2014 | 9/4/17 | A.B. Data, Ltd. | |
| Sauer-Danfoss Inc. | SHS | 3/15/2013 - 4/12/2013 | 9/14/17 | Analytics, Inc. | |
| Covenant Partners, L.P. (SEC Fair Fund) | n/a | 1/1/1999 - 12/31/2014 | TBD | Securities and Exchange Commission | |
| FX Instruments (Canada) (UBS/BNP/Bank of America) | n/a | 1/1/2003 - 12/31/2013 | TBD | TBD | |
| Computer Sciences Corporation (SEC Fair Fund) | CSC | 8/5/2008 - 12/27/2011 | TBD | Garden City Group |